Craig D. Wolfangel
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Advanced Chemical Physics Studies, Neuroscience and Neuropharmacology Research, Synthesis and biological activity
Most-Cited Works
- → Tyrosine Kinase Inhibitors. 6. Structure−Activity Relationships among N- and 3-Substituted 2,2‘-Diselenobis(1H-indoles) for Inhibition of Protein Tyrosine Kinases and Comparative in Vitro and in Vivo Studies against Selected Sulfur Congeners(1997)64 cited
- → Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor(2019)56 cited
- → Symmetry Breaking: Polymorphic Form Selection by Enantiomers of the Melatonin Agonist and Its Missing Polymorph(2012)20 cited
- → CCDC 887467: Experimental Crystal Structure Determination(2012)
- → CCDC 1944257: Experimental Crystal Structure Determination(2019)
- → CCDC 1944256: Experimental Crystal Structure Determination(2019)
- → CCDC 887469: Experimental Crystal Structure Determination(2012)
- → CCDC 1944255: Experimental Crystal Structure Determination(2019)
- → CCDC 887468: Experimental Crystal Structure Determination(2012)
- → CCDC 887466: Experimental Crystal Structure Determination(2012)